Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1612 1624
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18320928 | NANOSCALE COATINGS FOR ENCAPSULATION OF BIOLOGICAL ENTITIES | Non-Final OA | The Regents of the University of California |
| 17758059 | COSMETIC COMPOSITION COMPRISING A CATIONIC ASSOCIATIVE POLYMER, A CARBOXYLIC ANIONIC SURFACTANT, OPTIONALLY A NONIONIC SURFACTANT AND AN AMPHOTERIC OR ZWITTERIONIC SURFACTANT | Non-Final OA | L'Oreal |
| 18699670 | Microencapsulation | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18287009 | Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles | Non-Final OA | Board of Regents, The University of Texas System |
| 17615637 | Compositions of Dicarboxylic Acid Derivatives | Non-Final OA | UPL LTD |
| 18939439 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM | Non-Final OA | Cila Therapeutics Inc. |
| 18144382 | IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA | Non-Final OA | Wayne State University |
| 18684335 | BROAD SPECTRUM ANTI-MICROBIAL POLYMERIC COMPOSITION | Non-Final OA | CORNELL UNIVERSITY |
| 18245559 | Multi-targeting cell-derived nanoparticles as a versatile theranostic | Final Rejection | Fondazione Istituto Italiano di Tecnologia |
| 18392143 | COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO | Non-Final OA | The University of British Columbia |
| 18012611 | DRUG-LOADED POLYMER VESICLE HAVING ASYMMETRIC MEMBRANE STRUCTURE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF DRUGS FOR TREATING ACUTE MYELOID LEUKEMIA | Non-Final OA | SOOCHOW UNIVERSITY |
| 18591479 | STABILIZATION OF ADJUVANTED VACCINE COMPOSITIONS AND THEIR USE | Non-Final OA | Vaxcyte, Inc. |
| 18281915 | LIPID NANOPARTICLE PREPARATION METHOD AND PREPARATION APPARATUS THEREFOR | Non-Final OA | INVENTAGE LAB INC. |
| 18555439 | "Good" buffer-based cationic lipids | Final Rejection | TRANSLATE BIO, INC. |
| 18576244 | IONIZABLE LIPID COMPOUND FOR NUCLEIC ACID DELIVERY AND LNP COMPOSITION THEREOF | Non-Final OA | CANSINO (SHANGHAI) BIOLOGICAL RESEARCH CO., LTD. |
| 18570611 | SUB-MICRON PARTICLE | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18388724 | PARTICLE COMPOSITIONS COMPRISING POLYSARCOSINE LIPID CONJUGATES | Non-Final OA | CALUSA BIO, LLC |
| 18556287 | FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS | Non-Final OA | PERSEO PHARMA AG |
| 18381305 | BILIRUBIN NANOPARTICLE, USE THEREOF, AND PREPARATION METHOD THEREFOR | Final Rejection | BILIX CO., LTD. |
| 18280178 | PHARMACEUTICAL COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS THROUGH INFLAMMATION AMELIORATION OF HUMAN DERMAL PAPILLA CELLS AND PERIPHERAL CELLS AND INHIBITION OF 5A-REDUCTASE EXPRESSION | Non-Final OA | Jong Moon JEONG |
| 18547669 | CATIONIC POLYMER-FORMULATED NANOPARTICLES AND METHODS OF USE | Final Rejection | Ann and Robert H. Lurie Children's Hospital of Chicago |
| 18452418 | IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE | Non-Final OA | PDX Pharmaceuticals, Inc. |
| 18263955 | IONIZABLE LIPID MOLECULE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF LIPID NANOPARTICLE | Non-Final OA | IMMORNA (HANGZHOU) BIOTECHNOLOGY CO., LTD. |
| 18353524 | CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION | Non-Final OA | BREATH THERAPEUTICS GMBH |
| 17298156 | ANTIBODY FORMULATIONS | Non-Final OA | MORPHOSYS AG |
| 18270844 | USE OF PLANT-DERIVED EXOSOMES FOR INDUCING DIFFERENTIATION OF STEM CELL SOURCES INTO CARTILAGE AND BONE CELLS | Non-Final OA | YEDITEPE UNIVERSITESI |
| 18071705 | RNA FORMULATION FOR IMMUNOTHERAPY | Final Rejection | BioNTech SE |
| 18034242 | Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof | Final Rejection | Sanofi Pasteur |
| 18249753 | METHOD FOR PRODUCING RADIOACTIVE ZIRCONIUM COMPLEX | Non-Final OA | NIHON MEDI-PHYSICS CO., LTD. |
| 18122221 | SUGAR-COATED MELANIN NANOPARTICLES AND METHOD FOR TARGETING METASTATIC CANCER CELLS | Non-Final OA | THE TRUSTEES OF BOSTON COLLEGE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy